// App-Quantinova.ai

3818 : Characterization of Hypersensitivity Reactions Associated With Pegaspargase in Children With Acute Lymphoblastic Leukemia (ALL)

Researchers

Presenter

  • Di Sun

Principal Investigators

  • Bill Quach

  • Xiyan Li

  • Weili Sun

Medical Centers

  • University of Colorado Denver School of Medicine, Aurora, CO

  • Zhongshan School of Medicine, Guangzhou, China

  • Children's Hosp Los Angeles, Los Angeles, CA

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Pegaspargase

  • Oncaspar

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final